CDC Recommendations for Flu Treatment and Prophylaxis

CDC recommends neuraminidase inhibitors

According to the Centers for Disease Control (CDC), neuraminidase inhibitors are:

• Recommended for the treatment and prophylaxis of influenza²
• Effective against both influenza type A and B²

CDC continues to recommend neuraminidase inhibitors

• Since the 2004-2005 flu season, neuraminidase inhibitors have been recommended each year²
• Over the same period, CDC has not recommended use of older antivirals (M2 Inhibitors) due to high resistance potential²

CDC recommends neuraminidase inhibitors for treatment and prevention of influenza
type A and B.

Next topic: Neuraminidase Inhibitors

• Impact of the Flu
• Flu Contagiousness
• Influenza Diagnosis
• CDC Recommendations for Flu Treatment and Prophylaxis
  • Neuraminidase Inhibitors
• Flu Surveillance
• Patient Education About The Flu

• Impact of the Flu
• |
• Flu Contagiousness
• |
• Influenza Diagnosis
• |
• CDC Recommendations for Flu Treatment and Prophylaxis
• 
  
• Flu Surveillance
• |
• Patient Education About the Flu
• |
• Contact Us
• |
• Roche Antiviral Medication
• |
• fluFACTS.com Consumer Web site